EverGlade Consulting Helps Land up to $1 Billion in BARDA Funding for Biotechnology Company - EverGlade Consulting

EverGlade Consulting Helps Land up to $1 Billion in BARDA Funding for Biotechnology Company

Antibodies 3d illustration

EverGlade Consulting has helped a leading biotechnology company land an award from the Biomedical Advanced Research and Development Authority (BARDA) with a potential $1 billion in federal funding.

EVERGLADE helps secure BARDA funding for GEOVAX

EverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA Funding

Read More
office-specific funding opportunities

ARPA-H Announces Mission Office-Specific Funding Opportunities

Read More
Cancer therapy testing

ARPA-H Seeks Revolutionary Solutions for Precision Cancer Therapy Through ADAPT Program

Read More
Scroll to Top
Flask with blue light

Webinar: R&D Funding in Life Sciences: What's Ahead in Trump 2.0?

Join us on Jan 15, 2025, at 12:00pm ET for a deep dive into the future of R&D Funding in Life Sciences.

Sign Up